The etiology of hydrocephalus refers to the underlying causes of the condition, which can vary widely depending on whether it is congenital or acquired. Hydrocephalus is typically characterized by the abnormal accumulation of cerebrospinal fluid (CSF) within the ventricles of the brain, leading to increased intracranial pressure. This condition can result from several different causes, and understanding its etiology is crucial for diagnosis, treatment, and prevention.
### 1. Congenital Hydrocephalus
### 2. Acquired Hydrocephalus Acquired hydrocephalus develops after birth, often due to head injury, infection, or other neurological conditions that affect the normal flow of CSF. Common causes of acquired hydrocephalus include:
#### a. Traumatic Brain Injury (TBI)
#### b. Infections
#### c. Brain Tumors
#### d. Subarachnoid Hemorrhage (SAH)
#### e. Hydrocephalus Ex-Vacuo
#### f. Normal Pressure Hydrocephalus (NPH)
### 3. Genetic and Syndromic Causes Some genetic conditions are associated with an increased risk of developing hydrocephalus, often due to abnormalities in the CSF circulation system. Common syndromic causes include:
- X-linked hydrocephalus: A genetic disorder linked to mutations in the L1CAM gene, leading to obstructive hydrocephalus. - Dandy-Walker Syndrome: A congenital malformation involving the cerebellum and the fourth ventricle, often leading to hydrocephalus. - Apert Syndrome and other craniofacial syndromes: These can be associated with abnormal development of the skull and brain, resulting in hydrocephalus.
### 4. Obstruction of CSF Circulation Hydrocephalus can occur when there is physical obstruction to the flow of CSF. Common causes of CSF obstruction include:
- Congenital defects, such as aqueductal stenosis or Chiari malformations. - Acquired obstructions, such as brain tumors, cysts, or scar tissue from infection or injury.
### Conclusion: The etiology of hydrocephalus is multifactorial, involving a combination of genetic, developmental, environmental, traumatic, and pathological factors. Understanding the underlying cause of hydrocephalus is critical for determining the most appropriate treatment and management strategies, as different causes may require different interventions. Advances in neuroimaging, genetic research, and the development of improved surgical techniques are continuously enhancing our ability to diagnose and treat hydrocephalus more effectively.
A range of neurological pathologies may lead to secondary hydrocephalus.
see Pediatric Hydrocephalus Etiology
Acquired
a) infectious (the most common cause of communicating HCP)
● post-meningitis; especially purulent and basal, including TB, cryptococcus
b) post-hemorrhagic (2nd most common cause of communicating HCP)
● post-SAH
● post-intraventricular hemorrhage (IVH): many will develop transient HCP. 20–50% of patients with large IVH develop permanent HCP, requiring a shunt
Congenital (without myelomeningocele) 38%
Congenital (with myelomeningocele) 29%
Perinatal hemorrhage 11%
Traumatic subarachnoid hemorrhage 4.7%
Tumor 11%
Previous infection 7.6%
c) secondary to masses
● non neoplastic: e.g. vascular malformation
● neoplastic: most produce obstructive hydrocephalus by blocking CSF pathways, especially tumors around aqueduct (e.g. medulloblastoma). A colloid cyst can block CSF flow at the foramen of Monro.
Pituitary tumor: suprasellar extension of tumor or expansion from pituitary apoplexy
d) post-op: 20% of pediatric patients develop permanent hydrocephalus (requiring shunt) following p-fossa tumor removal. May be delayed up to 1 yr
f) “constitutional ventriculomegaly”: asymptomatic. Needs no treatment
Hydrocephalus has many causes:
Posthemorrhagic hydrocephalus.
Neurofibromatosis type 1 related hydrocephalus
Congenital hydrocephalus, most commonly involving aqueductal stenosis, has been linked to genes that regulate brain growth and development.
Newborn infants with germinal matrix hemorrhage.
Hydrocephalus can also be acquired, mostly from pathological processes that affect ventricular outflow, subarachnoid space function, or cerebral venous compliance.
Spontaneous subarachnoid hemorrhage/Aneurysmal subarachnoid hemorrhage.
Hydrocephalus after decompressive craniectomy.
Terminal deletion of chromosome 6q is a rare chromosomal abnormality associated with intellectual disabilities and various structural brain abnormalities.
Iwamoto et al. presented a case of 6q terminal deletion syndrome with unusual magnetic resonance imaging (MRI) findings in a neonate.
The neonate, who was prenatally diagnosed with dilation of both lateral ventricles, was born at 38 weeks of gestation. MRI demonstrated an abnormal membranous structure continuing to the hypertrophic massa intermedia in the third ventricle that had obscured the cerebrospinal fluid pathway, causing hydrocephalus. G-band analysis revealed a terminal deletion of 6q with the karyotype 46, XY, add(6)(q25.3) or del(6)(q26). He underwent ventriculoperitoneal shunt successfully, and his head circumference has been stable.
6q terminal deletion impacts the molecular pathway, which is an essential intracellular signaling cascade inducing neurological proliferation, migration, and differentiation during neuronal development. In patients with hydrocephalus in association with hypertrophy of the massa intermedia, this chromosomal abnormality should be taken into consideration. This case may offer an insight into the hydrocephalus etiology in this rare chromosomal abnormality 1).